- Home
- REE vs ANEB Comparison
REE vs ANEB Comparison
Compare REE & ANEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REE
- ANEB
- Stock Information
- Founded
- REE 2011
- ANEB 2020
- Country
- REE Israel
- ANEB United States
- Employees
- REE N/A
- ANEB N/A
- Industry
- REE Auto Manufacturing
- ANEB Biotechnology: Pharmaceutical Preparations
- Sector
- REE Consumer Discretionary
- ANEB Health Care
- Exchange
- REE Nasdaq
- ANEB Nasdaq
- Market Cap
- REE 52.8M
- ANEB 54.8M
- IPO Year
- REE N/A
- ANEB 2021
- Fundamental
- Price
- REE $6.18
- ANEB $2.00
- Analyst Decision
- REE Buy
- ANEB Strong Buy
- Analyst Count
- REE 4
- ANEB 3
- Target Price
- REE $9.25
- ANEB $6.67
- AVG Volume (30 Days)
- REE 767.5K
- ANEB 4.1K
- Earning Date
- REE 09-26-2024
- ANEB 11-12-2024
- Dividend Yield
- REE N/A
- ANEB N/A
- EPS Growth
- REE N/A
- ANEB N/A
- EPS
- REE N/A
- ANEB N/A
- Revenue
- REE $1,768,000.00
- ANEB N/A
- Revenue This Year
- REE $31,642.54
- ANEB N/A
- Revenue Next Year
- REE N/A
- ANEB N/A
- P/E Ratio
- REE N/A
- ANEB N/A
- Revenue Growth
- REE N/A
- ANEB N/A
- 52 Week Low
- REE $2.30
- ANEB $1.62
- 52 Week High
- REE $8.43
- ANEB $3.61
- Technical
- Relative Strength Index (RSI)
- REE 76.84
- ANEB 49.93
- Support Level
- REE $2.91
- ANEB $1.83
- Resistance Level
- REE $3.68
- ANEB $2.09
- Average True Range (ATR)
- REE 0.50
- ANEB 0.13
- MACD
- REE 0.29
- ANEB 0.04
- Stochastic Oscillator
- REE 85.16
- ANEB 46.67
About REE REE Automotive Ltd.
REE Automotive Ltd is an automotive technology company focused on building commercial electric vehicles controlled fully by-wire. The company is developing REEcorner technology which packs critical vehicle components into a single compact module positioned between the chassis and the wheel as well as building commercial Electric Vehicles (EV) leveraging REEcorner technology. The company has geographical preference in Israel, Germany, United States, United Kingdom, and other regions.
About ANEB Anebulo Pharmaceuticals Inc.
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company. It is developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations.